Literature DB >> 24796921

Nutrient free flaps with vascular bypasses for extremity salvage in patients with chronic limb ischemia.

R E Horch1, W Lang, A Arkudas, C Taeger, U Kneser, M Schmitz, J P Beier.   

Abstract

AIM: Treatment of severe wounds remains a surgical challenge in patients with critical limb ischemia (CLI). In some patients with end stage disease a combined arterial and venous vascular bypass together with immediate or subsequent free soft tissue transfer can become necessary to salvage the limb. The aim of this paper was to develop an algorithm of differential approaches of interdisciplinary reconstructions with bypasses and free flaps for leg salvage.
METHODS: From our experiences with over 76 patients receiving a vascular bypass and a free microsurgical tissue transfer, we analyzed the various configurations of possible vascular constellations and treatment options. We derived an algorithm for the combined interdisciplinary surgical approach.
RESULTS: We found the surgical technique to be one of the main predictors for the final outcome and categorized the various options and vascular configurations in combination with free flaps to salvage extremities. The overall complication rate with more than 20% revisional surgeries is higher than in routine free flap transfer for reconstructions in patient without CLI. We observed 3 failures (4%) with complete flap loss and bypass occlusion and found 3 patients (4%) with initially successful reconstructions to have secondary amputations within 6 to 18 months postoperatively.
CONCLUSION: Given the multitude of concomitant diseases in patients with serious wounds and CLI the distinct choice of the individual reconstructive vascular/flap-procedure has to be thoroughly selected. Any treatment decision against revascularization must be made only with proper and adequate diagnosis based on proper and sufficient diagnostic imaging techniques following an interdisciplinary discussion of possible options for limb salvage. Based on our experience with a large series of this type of combined revascularization-flap reconstruction we developed a specific algorithm of surgical variants of bypass-free flap arterial and venous reconstructions that is presented in this paper.

Entities:  

Mesh:

Year:  2014        PMID: 24796921

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  6 in total

1.  Distal pedal bypasses combined with free microsurgical flaps in chronic limb ischaemia for problematic wounds.

Authors:  Raymund E Horch; Werner Lang; Alexander Meyer; Marweh Schmitz
Journal:  Int Wound J       Date:  2014-05-02       Impact factor: 3.315

Review 2.  [Avoidance of complications in oncological surgery of the pelvic region : combined oncosurgical and plastic reconstruction measures].

Authors:  J P Beier; R S Croner; W Lang; A Arkudas; M Schmitz; J Göhl; W Hohenberger; R E Horch
Journal:  Chirurg       Date:  2015-03       Impact factor: 0.955

3.  Simultaneous femoro-popliteal artery bypass and foot free flap for lower limb salvage: a 13-year follow-up.

Authors:  Marius M Fodor; Lucian Fodor
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

4.  Mesenchymal stem cells and myoblast differentiation under HGF and IGF-1 stimulation for 3D skeletal muscle tissue engineering.

Authors:  R Witt; A Weigand; A M Boos; A Cai; D Dippold; A R Boccaccini; D W Schubert; M Hardt; C Lange; A Arkudas; R E Horch; J P Beier
Journal:  BMC Cell Biol       Date:  2017-02-28       Impact factor: 4.241

5.  Extracorporeal Free Flap Perfusion in Case of Prolonged Ischemia Time.

Authors:  C D Taeger; K Präbst; J P Beier; A Meyer; R E Horch
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-04-20

6.  Wound closure by means of free flap and arteriovenous loop: Development of flap autonomy in the long-term follow-up.

Authors:  Ulrich Rother; Helena Müller-Mohnssen; Werner Lang; Ingo Ludolph; Andreas Arkudas; Raymund E Horch; Susanne Regus; Alexander Meyer
Journal:  Int Wound J       Date:  2019-10-30       Impact factor: 3.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.